NEW YORK, May 1 (Reuters) - Purdue Pharma said ⁠on ⁠Friday that it has ceased ⁠operations and concluded its bankruptcy, re-emerging as a nonprofit focused on treating opioid addiction, overseen by a ...

Creditors of Purdue Pharma voted in favor of the opioid maker’s proposal to exit bankruptcy and pay billions to communities ...

Add Yahoo as a preferred source to see more of our stories on Google. Purdue Pharma, the maker of the prescription opioid OxyContin, is headquartered in this building at 201 Tresser Blvd., in downtown ...

Purdue Pharma, the bankrupted drug manufacturer at the center of the nation’s yearslong opioid epidemic, shut down May 1. The closure is part of a $7.4 billion deal reached after Purdue and the ...

In Purdue, the Supreme Court held that the Bankruptcy Code does not authorize a Chapter 11 plan to release and enjoin claims against a nondebtor without the consent of affected claimants. Harrington v ...

Most of the fines will go unpaid as part of $7.4 billion bankruptcy deal Victims and families express frustration over lack of accountability Judge says law limits punishment to fines, urges ...

Knoa Pharma's new CEO, Michael Goettler, will lead a company that was created through Purdue Pharma's bankruptcy process.

Add Yahoo as a preferred source to see more of our stories on Google. People march with pictures of loved ones who died from opioid overdoses during a protest outside the headquarters of Purdue Pharma ...

On March 31, 2026, US District Court Chief Judge Colm F. Connolly of the District of Delaware affirmed a bankruptcy court order recognizing Crédito Real, S.A.B. de C.V., SOFOM, E.N.R.’s (“Crédito Real ...